Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.